The Prognostic Value of Baseline PET/CT in Diffuse Large B-Cell Lymphoma Patients Treated with RCHOP

The Prognostic Value of Baseline PET/CT in Diffuse Large B-Cell Lymphoma Patients Treated with RCHOP

GUO Xiaochuan, ZHANG Weijing, ZHENG Pengteng, ZHANG Gui, CAO Baoping, HUANG Lefu, WANG Bin, WANG Weixia, ZHONG Kaili

PDF(1134 KB)

Welcome to Labeled Immunoassays and Clinical Medicine website! Share:

PDF(1134 KB)

Labeled Immunoassays and Clinical Medicine ›› 2021, Vol. 28 ›› Issue (10) : 1715-1720. DOI: 10.11748/bjmy.issn.1006-1703.2021.10.018

Clinical Investigation

The Prognostic Value of Baseline PET/CT in Diffuse Large B-Cell Lymphoma Patients Treated with RCHOP

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2021, 28(10): 1715-1720 https://doi.org/10.11748/bjmy.issn.1006-1703.2021.10.018

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}

{{article.copyrightLicense_en}}

PDF(1134 KB)

Accesses

Citation

Detail

Sections

Recommended

/

〈

〉